These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14093112)

  • 41. [Fundamentals in the therapy of hemorrhagic-traumatic shock conditions using plasma substitutes].
    Lundsgaard-Hansen P
    Schweiz Med Wochenschr; 1968 Aug; 98(34):1273-81. PubMed ID: 5682776
    [No Abstract]   [Full Text] [Related]  

  • 42. [Action, on blood pressure of the normal dog and the dog in hemorrhagic shock, of hypertonic sodium and glucose solutions of the same osmolarity].
    LABORIT H; NIAUSSAT P; WEBER B; JOUANY JM
    Anesth Analg (Paris); 1959; 16():557-61. PubMed ID: 14413221
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the efficacy of nonspecific bovine plasma in the treatment of hemorrhagic shock].
    BEAULNES A; TETREAULT L; BORDUAS A
    Rev Can Biol; 1962 Mar; 21():47-50. PubMed ID: 13866204
    [No Abstract]   [Full Text] [Related]  

  • 44. Portal pressure gradients in hemorrhagic shock.
    WIGGERS CJ; OPDYKE DF; JOHNSON JR
    Fed Proc; 1946; 5(1 Pt 2):113. PubMed ID: 21023568
    [No Abstract]   [Full Text] [Related]  

  • 45. [Blood substitutes: advantages and limitations in their use for treatment of hemorrhagic shock].
    WEIL P; BALDRY R
    Rev Belg Pathol Med Exp; 1955 Oct; 24(6):586-8. PubMed ID: 13298294
    [No Abstract]   [Full Text] [Related]  

  • 46. The metabolic response of the liver when acute experimental haemorrhagic shock is treated with dextran or gelatin-type plasma expanders.
    Hollmén A; Pihlajaniemi R; Reinilä M; Ryhänen P
    Ann Chir Gynaecol Fenn; 1972; 61(3):173-80. PubMed ID: 4639243
    [No Abstract]   [Full Text] [Related]  

  • 47. [Modezhel' erythrocyte preservative as an experimental and clinical blood substitute].
    Selivanov EA; Mel'nikova VN; Kochetygov NI; Pleshakov VT; Gerbut KA; Krivtsova IM; Lur'e GO
    Vestn Khir Im I I Grek; 1996; (1):71-4. PubMed ID: 8753967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infusion treatment in shock].
    Esser H
    Infusionsther Klin Ernahr; 1975 Dec; 2(6):424-8. PubMed ID: 1344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood volume and plasma protein. IV. Importance of thoracic-duct lymph in restitution of plasma volume and plasma proteins after bleeding and immediate substitution in the splenectomized dog.
    Liljedahl SO; Rieger A
    Acta Chir Scand Suppl; 1967; 379():39-5. PubMed ID: 5243639
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparison of dextran and gelatin as plasma substitutes].
    Lundsgaard-Hansen P; Riedwyl H; Hässig A
    Anaesthesist; 1967 Jul; 16(7):206-15. PubMed ID: 4872538
    [No Abstract]   [Full Text] [Related]  

  • 51. [Succinate-polymerized gelatin as a plasma substitute].
    Tosaki Y; Yasusumi N; Takaori M; Matsuki H; Okumura M
    Nihon Rinsho; 1968 May; 26(5):1227-33. PubMed ID: 5749805
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fundamentals in the therapy of hemorrhagic-traumatic shock conditions using plasms substitutes].
    Lundsgaard-Hansen P
    Schweiz Med Wochenschr; 1968 Aug; 98(35):1320-5 concl. PubMed ID: 5682109
    [No Abstract]   [Full Text] [Related]  

  • 53. Blood volume and plasma protein. 3. Changes in blood volume and plasma proteins after bleeding and immediate substitution with Macrodex, Rheomacrodex and Physiogel in the splenecromized dog.
    Rieger A
    Acta Chir Scand Suppl; 1967; 379():22-38. PubMed ID: 5243638
    [No Abstract]   [Full Text] [Related]  

  • 54. [Relationships between intravascular retention time, perfusion and metabolic dysregulation during infusion of colloidal and crystalloid solutions in hemorrhagic shock].
    Kilian J; Dölp R
    Bibl Haematol; 1971; 37():342-7. PubMed ID: 5138920
    [No Abstract]   [Full Text] [Related]  

  • 55. [SHOCK-LIKE SYMPTOMS IN SURGERY AND THEIR PREVENTION AND TREATMENT].
    HAYASHIDA T; MORIOKA K
    Jibiinkoka; 1963 Dec; 35():1025-32. PubMed ID: 14101113
    [No Abstract]   [Full Text] [Related]  

  • 56. [Peripheral blood circulation in hemorrhagic shock and effects of various plasma substitutes].
    Hara M
    Igaku Kenkyu; 1966 May; 36(3):305-20. PubMed ID: 6008561
    [No Abstract]   [Full Text] [Related]  

  • 57. THE EFFECT OF THE AMINE BUFFER TRIS (HYDROXYMETHYL) AMINO METHANE (THAM) ON THE RENAL BLOOD FLOW DURING HEMORRHAGIC SHOCK.
    GOETZ RH; SELMONOSKY CA; STATE D
    Surg Gynecol Obstet; 1963 Dec; 117():715-21. PubMed ID: 14100520
    [No Abstract]   [Full Text] [Related]  

  • 58. [THE EFFECT OF TRANSFUSION OF SOME BLOOD SUBSTITUTES AND BLOOD ON THE CORONARY CIRCULATION AND FUNCTIONAL STATE OF THE MYOCARDIUM UNDER CONDITIONS OF ACUTE BLOOD LOSS].
    KOFANOVA IuV
    Arkh Patol; 1965; 27():9-17. PubMed ID: 14321886
    [No Abstract]   [Full Text] [Related]  

  • 59. [Plasma substitutes in acute blood loss of the rabbit].
    Janzarik H; Lasch HG
    Helv Chir Acta; 1966 May; 33(3):392-403. PubMed ID: 5994659
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effect of blood transfusion and plasma substitutes on microcirculation during the late period of hemorrhagic shock].
    Glants RM; Vavriniuk AF
    Fiziol Zh (1978); 1983; 29(3):316-21. PubMed ID: 6873333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.